Research Article
The Increasing Financial Impact of Chronic Kidney Disease in Australia
Table 1
Current and projected prevalence rates and expenditure in Australia: 2012–2020.
| | | 2012 | 2020 | Percent Increase |
| | RRT Prevalence | 20,446 | 26,427 | 29% | | CVD Prevalence | 3.5 M | 3.8 M | 7% | | CKD-Related Expenditure | $1.3 B | $1.7 B | 37% | | RRT-Related Expenditure | $1.1 B | $1.5 B | 37% | | CVD-Related Expenditure | $6.9 B | $7.8 B | 14% | | Total Healthcare Expenditure | $131 B | $166 B | 26% | | RRT Per-Patient Expenditure | $54,930 | $63,677 | 16% | | CVD Per-Patient Expenditure | $1,954 | $2,109 | 8% | | Gross Domestic Product | $1.3 T | $1.8 T | 41% | | AU Population | $22.6 M | $25.0 M | 10% |
|
|
